Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
about
Nanotechnology and MRI contrast enhancementFunctional sorbents for selective capture of plutonium, americium, uranium, and thorium in bloodInteraction of Gd-DTPA with phosphate and phosphite: toward the reaction intermediate in nephrogenic systemic fibrosis.Conjugation of functionalized SPIONs with transferrin for targeting and imaging brain glial tumors in rat modelApplication of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.Gadofullerene MRI contrast agents.Biodistribution of gadolinium-based contrast agents, including gadolinium deposition.Nephrogenic systemic fibrosis in liver disease: a systematic review.Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis.The fate of Gd and chelate following intravenous injection of gadodiamide in rats.Quasi-cubic magnetite/silica core-shell nanoparticles as enhanced MRI contrast agents for cancer imagingNephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study.Macromolecular and dendrimer-based magnetic resonance contrast agents.Type of MRI contrast, tissue gadolinium, and fibrosis.Substitution of gadolinium ethylenediaminetetraacetate with phosphites: towards gadolinium deposit in nephrogenic systemic fibrosis.Responses of human skin in organ culture and human skin fibroblasts to a gadolinium-based MRI contrast agent: comparison of skin from patients with end-stage renal disease and skin from healthy subjects.Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis.An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis.Stimulation of fibroblast proliferation by insoluble gadolinium salts.Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.Total gadolinium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats.Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents.Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonanceChanging trends in a decade of vascular radiology-the impact of technical developments of non-invasive techniques on vascular imaging.USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure.Gadolinium and nephrogenic systemic fibrosis: time to tighten practice.Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging.Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature.Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.Nephrogenic systemic fibrosis: a nephrologist's perspective.Comparison of diagnostic accuracy of Doppler USG and contrast-enhanced magnetic resonance angiography and selective renal arteriography in patients with atherosclerotic renal artery stenosis.Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols.Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.Gadolinium and nephrogenic systemic fibrosis: association or causation.Scleroderma-like fibrosing disorders.Gadolinium - is it to blame?Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 casesAssociation of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis.
P2860
Q28307795-BBC8F0E0-5E1C-4ABE-8AF0-B8EDC8EEAA07Q28382820-3933F253-C236-482C-8B3C-FA5564C2A92BQ31048535-64420F72-76D8-402A-A002-869E427C2A26Q31061973-6A4DD740-64AB-4C46-AC8D-D695CF73420AQ31065446-5F470898-D7A0-4AA9-A30D-E6D0A52C421BQ31150936-C5F8C10E-A0DE-46F8-B892-A227DEB49C35Q33655413-E325DA16-6AAC-43AD-9007-674B856ECD29Q33748364-175E59F5-9D14-45BE-9D8A-4F7ACE21472CQ33822402-CEA6F0C0-40B7-4064-BCE5-3933845B0810Q33899096-A89F68AE-49B3-42FB-A6D6-CE013F0EB8EAQ33958115-12AD3983-79F2-442C-ABDE-C4F49732BAA2Q34056490-5D6FB498-8317-4515-AEC8-EDCFC1559FC1Q34069230-F8940419-D909-4305-A3F4-F4DDA8B4EC74Q34602036-875870D3-411B-45B4-83B2-DD2C615B6C43Q35019353-A443DB08-83A4-46A7-B44C-8A372699B306Q35187986-CBBACB88-316F-4E45-9CDA-E238E449EC11Q35573793-BA1870DB-3F44-4270-9681-FF6D8188F67FQ35664137-F68D2584-7A7F-4C96-82F9-E26A1D4D7FEBQ35740116-E8CB5CCC-F3D0-4B58-8700-F8F76D14D256Q35918597-DE0ED900-DD95-491C-94B1-296BFC3D92F9Q36027601-57EC37D5-0405-4E40-ABEF-FD58973E4B17Q36129149-3CC32367-1BB1-4C60-893E-7CA5AE1A18C5Q36130156-1E5011C9-AB40-44BE-B6A3-E031C6401F6EQ36236554-4728A8E2-4E00-4EAC-9054-11B1AEAF3382Q36346171-9B823AE5-6335-4391-8BA7-E98007A5264DQ36538610-BBC54F3E-882E-44D2-9BC6-3F0EAE6F911EQ36791108-BB32116C-5C9A-46D8-8B1E-3EFF1121159AQ36854172-23F5533D-0799-43E9-8D52-D911A7E61119Q36915537-86908A35-78E7-499B-AFB6-88BBA3D27D38Q36927735-76E361BA-E761-4DF5-8B1C-4778516D9403Q36952499-7E252A0D-2FC2-4A26-B682-EB2945FE146FQ36954689-85BC9C68-0852-4BA7-B287-9C44FE8B7905Q36974375-44391F03-A553-49B6-B8FE-ECCA770127EFQ36985258-66F9EB9B-3D7D-4946-AA8D-0A9C73D1D4B7Q37067538-E8587CA1-D00F-4A4C-8D49-AA4D97AD0841Q37105804-4BDB68F6-6B6E-4B25-BDD8-1D82188E466EQ37133328-34E2AEBE-26EA-4E79-B974-F5EBA03D3ADEQ37145493-B6DE93E7-95D4-4099-AC17-AA78F6614484Q37219177-B3132D3F-45EC-4B1F-B613-E2BF5A0BCA31Q37308825-D6C9A581-B160-4B41-A160-7159A9B42998
P2860
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Gadolinium is detectable withi ...... nephrogenic systemic fibrosis.
@ast
Gadolinium is detectable withi ...... nephrogenic systemic fibrosis.
@en
type
label
Gadolinium is detectable withi ...... nephrogenic systemic fibrosis.
@ast
Gadolinium is detectable withi ...... nephrogenic systemic fibrosis.
@en
prefLabel
Gadolinium is detectable withi ...... nephrogenic systemic fibrosis.
@ast
Gadolinium is detectable withi ...... nephrogenic systemic fibrosis.
@en
P2093
P1476
Gadolinium is detectable withi ...... nephrogenic systemic fibrosis.
@en
P2093
John Chandler
Reed A Ayers
Shawn E Cowper
Whitney A High
P356
10.1016/J.JAAD.2006.10.047
P407
P577
2006-11-09T00:00:00Z